FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

OMB OKs Info on Exemption for Preemption

11/16/2011

Federal Register Notice: FDA’s collection of information, “State Petitions for Exemption for Preemption,” has be...

Date Corrected in Guidance Notice

11/16/2011

Federal Register Notice: FDA is correcting a date in a 10/20 Federal Register notice announcing the availability of a draft guidan...

Comments on Allergic Disease Treatment Extended

11/16/2011

Federal Register Notice: FDA is extending to 4/25/12 the comment period for the notice on its report of scientific and medical lit...

Panel to Discuss Cranial Electrotherapy Device Reclassification

11/16/2011

Comments Sought on Device Mfr. Electronic Submissions

11/03/2011

Public Workshop on Developing Sedation Products

11/03/2011

Federal Register Notice: CDER will hold a scientific workshop 5/3/12 to solicit information on a variety of issues related to the ...

Animal Drug Sponsor Name Changed

11/10/2010

Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor's name from North American...

Amphetamine Sulfate Not Withdrawn for S&E

11/10/2010

Federal Register Notice: FDA has determined that amphetamine sulfate, 5 and 10 mg tablets, was not withdrawn from sale for reasons...

Special Control Guidance Available for Tissue Adhesive

11/10/2010

Federal Register Notice: FDA is making available a guidance entitled, Class 2 Special Controls Guidance Document: Tissue Adhesive ...

Comments Extended on PDUFA Reauthorization Meeting

11/10/2010

Federal Register Notice: FDA is reopening until 10/31/11 the comment period for the notice of public meeting that published in the...